GENPHARMA.BO
Get informed when a big investor buys or sells
+ Follow| Market cap | $564.79 Million |
|---|---|
| Enterprise Value | $564.79 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.01 |
| Beta | 0.11 |
| Outstanding Shares | 553,719,700 |
| P/E Ratio | -237.21 |
|---|---|
| PEG | 301.68 |
| Price to Sales | 0.34 |
| Price to Book Ratio | 1.02 |
| Enterprise Value to Revenue | 0.32 |
| Enterprise Value to EBIT | 391.95 |
| Enterprise Value to Net Income | -464 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Genpharmasec Ltd. conducd ts business primarily in the pharmaceutical sector, offering various related services, anactively participates in the equity markets through share trading. Its operational scope is delineated into two key divisi...